Guardant Health Shares Slide After Patent-Infringement Verdict
By Colin Kellaher Guardant Health shares fell sharply Wednesday after the precision-oncology company was hit with a patent-infringement verdict topping $80...
Source: marketwatch.com
Stay updated with breaking news from Duplex Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Colin Kellaher Guardant Health shares fell sharply Wednesday after the precision-oncology company was hit with a patent-infringement verdict topping $80...
Guardant Health Inc (NASDAQ: GH) shares are falling after the company announced it intends to appeal its verdict in the U.S.
TwinStrand Biosciences Expands Executive Team With Appointment of Goran Pljevaljcic as Chief Commercial Officer - read this article along with other careers information, tips and advice on BioSpace